DALLAS, June 2, 2005 (PRIMEZONE) -- TalkingStocks.com has issued a new Profile Report on MEDirect Latino (Pink Sheets:MLTO). The report is authored by Senior Investment Analyst, Shailesh Dhuri, CFA. In the report, Mr. Dhuri looks at recent developments and discusses the company in depth.
Mr. Dhuri concludes, "The Hispanic population of the U.S. represents a unique health-care market. The Medicare reimbursement procedures are found cumbersome by many Hispanic people, mainly due to language issues. Thus, a company which can offer tailored solutions to offer total healthcare services, including the Medicare reimbursements and that addresses the exact needs of the Hispanic market, may have a promising future."
To view the Profile Report, please visit: http://talkingstocks.com/reports/MLTO_060205.php
Registration is free.
About MEDirect Latino:
MEDirect Latino (Pink Sheets:MLTO), http://www.medirectlatino.org, is a rapidly growing, uniquely positioned provider of direct-to-consumer Medicare reimbursed medical products focused exclusively on chronic diseases afflicting the Hispanic community in the United States and Puerto Rico. MEDirect is the only company positioned to serve the U.S. Hispanic healthcare market as a direct-to-consumer Medicare provider on an authentically national level. The Company's current focus is the distribution of products for the treatment of Type II diabetes specifically because of its disproportionate impact and increasing diagnosis rate within the U.S. Hispanic population, noting an incidence of 120% higher than among non-Hispanic whites. Type II diabetes was also targeted because of its unique status within the Medicare reimbursement regime and because of its high degree of correlation to other chronic conditions such as high blood pressure and heart disease. These other conditions represent considerable future market potential that will allow MEDirect to efficiently scale its model by leveraging its existing client base and infrastructure.
The current Hispanic market for MEDirect's products is conservatively estimated at approximately $650MM in the continental United States. The size of the opportunity is understated by such figures as an estimated 925,000 of the over 3.1 million Hispanics in the United States over 65 eligible to receive Medicare benefits are currently collecting these benefits with an estimate that over 1.4 million of those Medicare-eligible Hispanics have diabetes (implying a potential continental U.S. market for MEDirect products of approximately $1 billion).
About TalkingStocks.com:
StockGuru.com and TalkingStocks.com are two key destinations on the internet for those seeking information on smallcap and microcap companies. The web sites feature companies in Profile Campaigns, Key Executive Interviews, email alerts and special reports authored by our financial writers. The web sites set the standard for communication with investors. To feature a company or to get more information, please contact our publisher, John Pentony, for more information (Telephone: 972-865-1401; Email: publisher@stockguru.com).
Forward-Looking Statements:
Statements about the Company's future expectations, including future revenues and earnings, and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as the term is defined in the Private Litigation Reform Act of 1995. The Company's actual results could differ materially from expected results. The Company undertakes no obligation to update forward-looking statements to reflect subsequently occurring events or circumstances. Should events occur which materially affect any comments made within this press release; the Company will appropriately inform the public.
Disclosure: Pentony Enterprises LLC and TalkingStocks.com LLC have been compensated $6,000 and 12,000 restricted shares by a third party company for profile coverage. Neither TalkingStocks.com, LLC, nor Pentony Enterprises, LLC, are registered investment advisers or broker/dealers. TalkingStocks.com, LLC and Pentony Enterprises, LLC makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable.